A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation.

about

Spotlight on elotuzumab in the treatment of multiple myeloma: the evidence to date The Cost Impact of Lenalidomide for Newly Diagnosed Multiple Myeloma in the EU5.Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting

P2860

Q28076147-F24CAAE0-56DB-412E-9030-3F5C2A47F04F Q53543459-3DEC108E-6245-45AB-9EAC-E073809B934B Q58560605-95129783-5942-4B53-8C70-23D84AE90DCA

P2860

A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation.

Item

http://www.wikidata.org/entity/Q38819936

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A systematic literature review ...... for stem cell transplantation.

@en

type

Item

label

A systematic literature review ...... for stem cell transplantation.

@en

prefLabel

A systematic literature review ...... for stem cell transplantation.

@en

P1476

A systematic literature review ...... for stem cell transplantation.

@en

P2093

Adrian Yee

http://www.w3.org/2001/XMLSchema#string

Amber Martin

http://www.w3.org/2001/XMLSchema#string

Catarina Geraldes

http://www.w3.org/2001/XMLSchema#string

Chantal Doyen

http://www.w3.org/2001/XMLSchema#string

Eric Druyts

http://www.w3.org/2001/XMLSchema#string

Eric Voog

http://www.w3.org/2001/XMLSchema#string

Jan Van Droogenbroeck

http://www.w3.org/2001/XMLSchema#string

Jin Lu

http://www.w3.org/2001/XMLSchema#string

Juan José Lahuerta

http://www.w3.org/2001/XMLSchema#string

Kabirraaj Toor

http://www.w3.org/2001/XMLSchema#string

P2860

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

Practical methods for incorporating summary time-to-event data into meta-analysis

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

Combination of direct and indirect evidence in mixed treatment comparisons

Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials.

Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma.

Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials.

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

P304

153-161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1080/10428194.2016.1177772

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Meletios A. Dimopoulos

Thierry Facon

Katja Weisel

P577

2016-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27124703

http://www.w3.org/2001/XMLSchema#string

A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation.

about

P2860

P2860

A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698